- Home
- ISPR vs BTMD Comparison
ISPR vs BTMD Comparison
Compare ISPR & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPR | BTMD |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.6M | 90.6M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | ISPR | BTMD |
|---|---|---|
| Price | $2.65 | $2.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $7.50 | $6.00 |
| AVG Volume (30 Days) | 44.0K | ★ 132.4K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | $118,506,875.00 | ★ $195,645,000.00 |
| Revenue This Year | $11.60 | N/A |
| Revenue Next Year | $40.79 | $2.80 |
| P/E Ratio | ★ N/A | $3.47 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $1.44 | $2.32 |
| 52 Week High | $6.38 | $6.70 |
Technical Indicators
Market Signals| Indicator | ISPR | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 60.28 | 51.62 |
| Support Level | $2.37 | $2.32 |
| Resistance Level | $2.67 | $2.90 |
| Average True Range (ATR) | 0.23 | 0.14 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 91.47 | 51.22 |
Price Performance
Historical ComparisonAbout ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.